Guggenheim Capital LLC Medicinova Inc Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$7.96 - $13.23 $91,540 - $152,145	-11,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $75,900 - $159,965	11,500 New	11,500 $116,000
Q4 2017 Feb 14, 2018	SELL	$5.89 - $7.21 $60,625 - $74,212	-10,293 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.43 - $6.58 $45,597 - $67,727	10,293	10,293 $65,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.